Laparoscopic ischemic conditioning prior esophagectomy in selected patients: the ISCON trial.

Eline de Groot, Lars M Schiffmann, Arjen van der Veen, Alicia Borggreve, Pim de Jong, Daniel Pinto Dos Santos, Benjamin Babic, Hans Fuchs, Jelle Ruurda, Christiane Bruns, Richard van Hillegersberg, Wolfgang Schröder
{"title":"Laparoscopic ischemic conditioning prior esophagectomy in selected patients: the ISCON trial.","authors":"Eline de Groot,&nbsp;Lars M Schiffmann,&nbsp;Arjen van der Veen,&nbsp;Alicia Borggreve,&nbsp;Pim de Jong,&nbsp;Daniel Pinto Dos Santos,&nbsp;Benjamin Babic,&nbsp;Hans Fuchs,&nbsp;Jelle Ruurda,&nbsp;Christiane Bruns,&nbsp;Richard van Hillegersberg,&nbsp;Wolfgang Schröder","doi":"10.1093/dote/doad027","DOIUrl":null,"url":null,"abstract":"<p><p>Anastomotic leakage (AL) after esophagectomy is the most impactful complication after esophagectomy. Ischemic conditioning (ISCON) of the stomach >14 days prior to esophagectomy might reduce the incidence of AL. The current trial was conducted to prospectively investigate the safety and feasibility of laparoscopic ISCON in selected patients. This international multicenter feasibility trial included patients with esophageal cancer at high risk for AL with major calcifications of the thoracic aorta or a stenosis in the celiac trunk. Patients underwent laparoscopic ISCON by occlusion of the left gastric and the short gastric arteries followed by esophagectomy after an interval of 12-18 days. The primary endpoint was complications Clavien-Dindo ≥ grade 2 after ISCON and before esophagectomy. Between November 2019 and January 2022, 20 patients underwent laparoscopic ISCON followed by esophagectomy. Out of 20, 16 patients (80%) underwent neoadjuvant treatment. The median duration of the laparoscopic ISCON procedure was 45 minutes (range: 25-230). None of the patients developed intraoperative or postoperative complications after ISCON. Hospital stay after ISCON was median 2 days (range: 2-4 days). Esophagectomy was completed in all patients after a median of 14 days (range: 12-28). AL occurred in three patients (15%), and gastric tube necrosis occurred in one patient (5%). In hospital, the 30-day and 90-day mortalities were 0%. Laparoscopic ISCON of the gastric conduit is feasible and safe in selected esophageal cancer patients with an impaired vascular status. Further studies have to prove whether this innovative strategy aids to reduce the incidence of AL.</p>","PeriodicalId":11255,"journal":{"name":"Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/dote/doad027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Anastomotic leakage (AL) after esophagectomy is the most impactful complication after esophagectomy. Ischemic conditioning (ISCON) of the stomach >14 days prior to esophagectomy might reduce the incidence of AL. The current trial was conducted to prospectively investigate the safety and feasibility of laparoscopic ISCON in selected patients. This international multicenter feasibility trial included patients with esophageal cancer at high risk for AL with major calcifications of the thoracic aorta or a stenosis in the celiac trunk. Patients underwent laparoscopic ISCON by occlusion of the left gastric and the short gastric arteries followed by esophagectomy after an interval of 12-18 days. The primary endpoint was complications Clavien-Dindo ≥ grade 2 after ISCON and before esophagectomy. Between November 2019 and January 2022, 20 patients underwent laparoscopic ISCON followed by esophagectomy. Out of 20, 16 patients (80%) underwent neoadjuvant treatment. The median duration of the laparoscopic ISCON procedure was 45 minutes (range: 25-230). None of the patients developed intraoperative or postoperative complications after ISCON. Hospital stay after ISCON was median 2 days (range: 2-4 days). Esophagectomy was completed in all patients after a median of 14 days (range: 12-28). AL occurred in three patients (15%), and gastric tube necrosis occurred in one patient (5%). In hospital, the 30-day and 90-day mortalities were 0%. Laparoscopic ISCON of the gastric conduit is feasible and safe in selected esophageal cancer patients with an impaired vascular status. Further studies have to prove whether this innovative strategy aids to reduce the incidence of AL.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
选择性患者食管切除术前腹腔镜局部缺血预处理:ISCON试验。
食管切除术后吻合口瘘(AL)是食管切除术最严重的并发症。食管切除术前14天以上的胃缺血预处理(ISCON)可能会降低AL的发生率。本试验旨在前瞻性研究腹腔镜ISCON在选定患者中的安全性和可行性。这项国际多中心可行性试验包括AL高危食管癌症患者,胸主动脉严重钙化或腹腔主干狭窄。患者通过阻断胃左动脉和胃短动脉进行腹腔镜ISCON,然后在间隔12-18天后进行食管切除术。主要终点是并发症Clavien-Dindo ≥ ISCON后和食管切除术前2级。2019年11月至2022年1月,20名患者接受了腹腔镜ISCON,随后进行了食管切除术。在20例患者中,16例(80%)接受了新辅助治疗。腹腔镜ISCON手术的中位持续时间为45分钟(范围:25-230)。ISCON后,没有患者出现术中或术后并发症。ISCON后的住院时间中位数为2天(范围:2-4天)。所有患者均在中位14天后完成食道切除术(范围:12-28)。AL发生在3例患者中(15%),而胃导管坏死发生在1例患者(5%)。在医院,30天和90天的死亡率为0%。腹腔镜胃导管ISCON对某些血管受损的食管癌症患者是可行和安全的。进一步的研究必须证明这种创新策略是否有助于降低AL的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Association of perioperative oral swallowing function with post-esophagectomy outcomes and nutritional statuses in patients with esophageal cancer. Safety and efficacy of EsoFLIP dilation in patients with esophageal dysmotility: a systematic review. Esophagogastroduodenoscopy findings that do no not explain dysphagia are associated with underutilization of high-resolution manometry. Risk of metastasis among patients diagnosed with high-risk T1 esophageal adenocarcinoma who underwent endoscopic follow-up. Evaluation of indocyanine green tracheobronchial fluorescence (ICG-TBF) via nebulization during minimally invasive esophagectomy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1